Abstract:
Objective To explore the application value of combined detection of serum tumor markers carbohydrate antigen 125 (CA125), carbohydrate antigen 199 (CA199), carbohydrate antigen 72-4 (CA72-4), and carcinoembryonic antigen (CEA) in gastrointestinal tumors.
Methods Clinical data of 158 patients with gastrointestinal tumors (observation group) and 46 patients with benign gastrointestinal lesions (control group) were randomly selected for retrospective analysis.CA125, CA199, CA72-4, and CEA were detected in the two groups and statistically analyzed to evaluate the application value of CA125, CA199, CA72-4, and CEA in patients with gastrointestinal tumors.
Results The levels of CA125, CA199, CA72-4, and CEA in the observation group were significantly higher than those in the control group (P < 0.01).The levels of CA125, CA199, CA72-4, and CEA in gastrointestinal tumors of different pathological differentiation types were as follows: well differentiated adenocarcinoma < moderately differentiated adenocarcinoma < poorly differentiated adenocarcinoma, with statistically significant differences (P < 0.05 to P < 0.01).The levels of CA125, CA199, CA72-4, and CEA in gastrointestinal tumors with lymph node metastasis were higher than those without lymph node metastasis (P < 0.05 to P < 0.01).The AUC of the ROC curve for the combined detection of CA125, CA199, CA72-4, and CEA in the diagnosis of gastrointestinal tumors was higher than that of the individual detection of the above four indicators, and the difference was statistically significant (P < 0.01).
Conclusions The combined detection of CA125, CA199, CA72-4, and CEA in patients with gastrointestinal tumors can provide a basis for clinical diagnosis of gastrointestinal tumors, and can also accurately analyze their condition, which is beneficial for understanding the pathological differentiation and lymph node metastasis of tumors.